Literature DB >> 10391398

Plasma 1,5-anhydroglucitol concentrations are influenced by variations in the renal threshold for glucose.

E S Kilpatrick1, B G Keevilt, K L Richmond, P Newland, G M Addison.   

Abstract

AIMS: Measurement of serum 1,5-anhydroglucitol (1,5AG) concentrations has been proposed as an alternative to HbA1c as both a marker of diabetic glycaemic control and as a screening test for diabetes. The sugar competes with glucose for renal tubular reabsorption, so hyperglycaemia leads to reduced serum 1,5AG concentrations through increased urinary loss. This study has sought to establish whether plasma 1,5AG can be influenced by not only hyperglycaemia, but by variations in renal threshold for glucose.
METHODS: Thirty-eight pregnant women (median age 30 years, range 20-43) found to be normoglycaemic after a 75-g carbohydrate load had plasma 1,5AG and urine glucose measured.
RESULTS: Using multivariate analysis, the presence and degree of detectable glycosuria at 2 h post glucose load was strongly predictive of a low plasma 1,5AG concentration (P=0.0012) independently of fasting plasma glucose (P=0.96), 2 h glucose (P=0.029), subject age (P=0.97) and gestation (P=0.36). Thus, when matched for plasma glucose areas under the glucose load curve, 16 glycosuric subjects had significantly lower 1,5AG concentrations compared to 16 nonglycosuric ones (median 1,5AG 46 micromol/l (IQR 30-56) vs. 72 micromol/l (IQR 55-79, P=0.017).
CONCLUSIONS: People with the same glucose tolerance may demonstrate variable plasma 1,5AG concentrations depending on their renal threshold for glucose. This inherent characteristic is likely to limit the usefulness of the test when monitoring or screening for diabetes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10391398     DOI: 10.1046/j.1464-5491.1999.00093.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  16 in total

1.  Metabolomic analysis of exercise effects in the POLG mitochondrial DNA mutator mouse brain.

Authors:  Joanne Clark-Matott; Ayesha Saleem; Ying Dai; Yevgeniya Shurubor; Xiaoxing Ma; Adeel Safdar; Myron Flint Beal; Mark Tarnopolsky; David K Simon
Journal:  Neurobiol Aging       Date:  2015-07-21       Impact factor: 4.673

2.  Evaluation of 1,5-anhydroglucitol, hemoglobin A1c, and glucose levels in youth and young adults with type 1 diabetes and healthy controls.

Authors:  Sanjeev N Mehta; Natalie Schwartz; Jamie R Wood; Britta M Svoren; Lori Mb Laffel
Journal:  Pediatr Diabetes       Date:  2011-11-08       Impact factor: 4.866

3.  Diagnostic value of glycemic markers HbA1c, 1,5-anhydroglucitol and glycated albumin in evaluating gestational diabetes mellitus.

Authors:  Baris Saglam; Sezer Uysal; Sadik Sozdinler; Omer Erbil Dogan; Banu Onvural
Journal:  Ther Adv Endocrinol Metab       Date:  2017-11-23       Impact factor: 3.565

4.  Serum 1,5-anhydroglucitol concentrations are a reliable index of glycemic control in type 2 diabetes with mild or moderate renal dysfunction.

Authors:  Won Jun Kim; Cheol-Young Park; Kyu-Beck Lee; Se Eun Park; Eun Jung Rhee; Won Young Lee; Ki Won Oh; Sung Woo Park
Journal:  Diabetes Care       Date:  2011-12-30       Impact factor: 19.112

5.  Association of hemoglobin A1c and glycated albumin with carotid atherosclerosis in community-dwelling Japanese subjects: the Hisayama Study.

Authors:  Naoko Mukai; Toshiharu Ninomiya; Jun Hata; Yoichiro Hirakawa; Fumie Ikeda; Masayo Fukuhara; Taeko Hotta; Masafumi Koga; Udai Nakamura; Dongchon Kang; Takanari Kitazono; Yutaka Kiyohara
Journal:  Cardiovasc Diabetol       Date:  2015-06-24       Impact factor: 9.951

6.  A computational model of 1,5-AG dynamics during pregnancy.

Authors:  Seyedeh M Zekavat; Slava Butkovich; Grace J Young; David M Nathan; Danny Petrasek
Journal:  Physiol Rep       Date:  2017-08

7.  Evaluation of serum 1,5 anhydroglucitol levels as a clinical test to differentiate subtypes of diabetes.

Authors:  Aparna Pal; Andrew J Farmer; Christina Dudley; Mary P Selwood; Beryl A Barrow; Rhiannon Klyne; Jilly P Grew; Mark I McCarthy; Anna L Gloyn; Katharine R Owen
Journal:  Diabetes Care       Date:  2009-11-23       Impact factor: 19.112

8.  1,5-Anhydroglucitol as a marker of maternal glycaemic control and predictor of neonatal birthweight in pregnancies complicated by type 1 diabetes mellitus.

Authors:  N Nowak; J Skupien; K Cyganek; B Matejko; M T Malecki
Journal:  Diabetologia       Date:  2013-02-02       Impact factor: 10.122

9.  Clinical application of 1,5-anhydroglucitol measurements in patients with hepatocyte nuclear factor-1alpha maturity-onset diabetes of the young.

Authors:  Jan Skupien; Sylwia Gorczynska-Kosiorz; Tomasz Klupa; Krzysztof Wanic; Eric A Button; Jacek Sieradzki; Maciej T Malecki
Journal:  Diabetes Care       Date:  2008-05-20       Impact factor: 19.112

10.  Thresholds of various glycemic measures for diagnosing diabetes based on prevalence of retinopathy in community-dwelling Japanese subjects: the Hisayama Study.

Authors:  Naoko Mukai; Miho Yasuda; Toshiharu Ninomiya; Jun Hata; Yoichiro Hirakawa; Fumie Ikeda; Masayo Fukuhara; Taeko Hotta; Masafumi Koga; Udai Nakamura; Dongchon Kang; Takanari Kitazono; Yutaka Kiyohara
Journal:  Cardiovasc Diabetol       Date:  2014-02-17       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.